Selenium Sex- and Cycle-Related Differences: Normal Range, Optimal Levels, and What Changes Your Results

What Is the Normal and Optimal Range for Selenium?

Serum selenium between 70 and 150 µg/L covers most healthy adults in the United States, but "normal" and "optimal" are not the same number. Glutathione peroxidase (GPx) activity, the most studied functional endpoint, saturates at roughly 90 µg/L. Selenoprotein P, the main plasma transport protein and a second functional marker, does not fully saturate until serum selenium reaches approximately 90 to 125 µg/L, depending on the assay and the population studied.

Reference Range vs. Functional Saturation

The CDC Second National Report on Biochemical Indicators of Diet and Nutrition found median serum selenium in US adults to be approximately 136 µg/L, well above the GPx saturation point, but population medians disguise the subset sitting below 90 µg/L who carry subclinical functional deficiency. A 2011 cross-sectional analysis of NHANES data (N=13,887) confirmed that serum selenium below 100 µg/L was associated with higher all-cause mortality over 18 years of follow-up, with a hazard ratio of 1.22 (95% CI 1.05 to 1.41; P<0.01).

Why 90 to 120 µg/L Is the Practical Target

Below 90 µg/L, GPx activity is measurably reduced. Above 120 to 125 µg/L, additional selenium provides diminishing enzymatic returns and begins accumulating in non-selenoprotein pools. The SELECT trial (N=35,533) found that men who entered the study with baseline serum selenium above 170 µg/L and then supplemented 200 µg/day of selenomethionine saw a statistically non-significant increase in high-grade prostate cancer risk (HR 1.22; P=0.06), underscoring the narrow therapeutic window. Targeting 90 to 120 µg/L keeps selenoproteins saturated without pushing into the range where excess selenium accumulates.

How Sex Affects Selenium Status

Men consistently test higher than women in population studies. The gap is not trivial. A 2014 European multi-country cohort study (N=2,978) reported mean serum selenium of 91.0 µg/L in women versus 99.4 µg/L in men after adjusting for age and BMI. A US analysis of NHANES 2011 to 2016 data confirmed the same direction, with women averaging 133 µg/L versus men at 141 µg/L.

Biological Drivers of the Sex Gap

Three mechanisms account for most of the difference.

Body composition. Selenium distributes into lean tissue, particularly skeletal muscle. Men carry more lean mass per kilogram of body weight, so total body selenium stores are larger even when dietary intake is identical.

Estrogen and selenoprotein expression. Estrogen upregulates expression of selenoprotein P and thioredoxin reductase (TrxR) in hepatic tissue, which sounds beneficial, but higher hepatic turnover also increases urinary selenium excretion. A mechanistic study in rodent models showed that estradiol administration increased renal selenium clearance by approximately 18% compared with ovariectomized controls. Whether this fully explains the human sex gap remains under investigation.

Reproductive losses. Menstrual blood contains measurable selenium. Estimates from balance studies place monthly menstrual selenium loss at 1 to 3 µg per cycle, small in absolute terms but additive over years of cycling.

Testosterone and Selenium in Men

Testosterone and selenium share a relationship that goes both directions. A cross-sectional analysis published in the Journal of Trace Elements in Medicine and Biology (N=690 men) found that serum selenium below 85 µg/L was associated with lower total testosterone (mean 4.1 ng/mL vs. 5.3 ng/mL in men above 100 µg/L; P<0.001). Leydig cells express GPx and TrxR; oxidative stress within testicular tissue impairs steroidogenesis, and selenium-dependent antioxidant enzymes reduce that stress.

Selenium and the Menstrual Cycle

Serum selenium is not static across a 28-day cycle. Small but consistent fluctuations track the hormonal shifts of the follicular and luteal phases.

Follicular Phase: Baseline Status

During the follicular phase (days 1 to 14), estrogen rises gradually from its menstrual nadir toward the pre-ovulatory surge. Serum selenium during this phase reflects dietary intake most faithfully because hormone-driven redistribution is minimal. Clinicians timing a selenium test for a premenopausal woman should prefer days 3 to 7 of the cycle, when results are most stable and least influenced by luteal-phase physiology.

Luteal Phase: The Progesterone Effect

After ovulation, progesterone rises sharply. A paired-measurement study in 32 healthy women (ages 20 to 35) found serum selenium fell by a mean of 6.2 µg/L (approximately 5 to 7%) from the follicular to the mid-luteal phase, coinciding with peak progesterone. The proposed mechanism is progesterone-driven expansion of plasma volume and increased hepatic selenoprotein synthesis that temporarily pulls circulating selenium into tissue. The drop is modest, but it can push a borderline-low result into the flagged range if the test happens to be drawn at day 20 to 22.

Practical Implication for Test Interpretation

A serum selenium of 82 µg/L drawn on day 21 of a cycle may reflect a true status of 88 µg/L when corrected for luteal-phase dilution. Reporting sex and cycle day alongside the lab value is standard practice in fertility and thyroid clinics but uncommon in general primary care, a gap worth closing.

Selenium in Pregnancy and Postpartum

Pregnancy imposes the largest physiological drop in selenium status outside of severe dietary restriction. Plasma volume expands by 40 to 50% by the third trimester, diluting all circulating minerals. Beyond dilution, selenium is actively transferred to the fetus via placental selenoprotein P transport.

Trimester-by-Trimester Pattern

A longitudinal cohort study (N=214) published in the British Journal of Nutrition measured serum selenium at each trimester: mean 75.1 µg/L in the first trimester, 67.3 µg/L in the second, and 62.8 µg/L in the third, a 16% fall from first to third trimester. All three trimester means were below the 90 µg/L functional saturation threshold, meaning the majority of these women carried measurably reduced GPx activity through most of pregnancy.

Thyroid Risk in Pregnancy

Selenium deficiency in pregnancy compounds iodine-related thyroid risk. Type 1 and type 3 iodothyronine deiodinases (DIO1, DIO3) are selenoproteins. When selenium falls below 60 µg/L, DIO3 activity drops and fetal T3 regulation becomes imprecise. The SELENA study, a randomized controlled trial (N=169 pregnant women), found that 60 µg/day of selenomethionine supplementation from the first trimester normalized serum selenium to approximately 89 µg/L by the third trimester and reduced postpartum thyroiditis incidence from 48.6% in the placebo group to 28.6% in the treated group (P=0.013).

Postpartum Recovery

Serum selenium recovers within 6 to 12 weeks postpartum in women who resume adequate dietary intake. Breastfeeding extends the demand: human breast milk contains 15 to 25 µg/L of selenium, and a mother producing 750 mL/day exports roughly 11 to 19 µg of selenium daily. Women with limited seafood or nut intake who exclusively breastfeed for 6 months should have selenium checked at the 6-week postpartum visit.

Selenium and Thyroid Hormone Conversion

The thyroid connection is the most clinically consequential reason to monitor selenium in hormonal medicine. The deiodinase enzymes that convert thyroxine (T4) to active triiodothyronine (T3), and that inactivate both hormones through inner-ring deiodination, are all selenoproteins.

DIO1, DIO2, and DIO3: What Each Needs

DIO1 handles bulk T4-to-T3 conversion in the liver and kidney. DIO2 generates local T3 in the pituitary, brown adipose tissue, and brain. DIO3 inactivates T3 and converts T4 to reverse T3 (rT3). When selenium is low, all three enzymes are affected, but the clinical result is often an elevated rT3-to-T3 ratio and a pattern that mimics euthyroid sick syndrome on labs, even when TSH is technically normal.

TSH Can Look Normal Despite Functional Deficiency

A study of 2,143 subjects in a selenium-depleted region of Germany found that TPO antibody titers fell significantly in subjects supplemented with 200 µg/day of selenomethionine for 9 months, with median anti-TPO dropping from 1,350 IU/mL to 640 IU/mL (P<0.0001), while TSH remained in the normal range throughout. TSH cannot detect the subcellular deiodinase impairment that selenium deficiency causes.

Hashimoto's Thyroiditis: A Special Case

A meta-analysis of 9 randomized controlled trials (total N=586) published in Thyroid found that selenium supplementation (100 to 200 µg/day) reduced anti-TPO antibodies by a weighted mean of 49.5% and anti-thyroglobulin antibodies by 40.2% compared with placebo after 3 to 12 months. The American Thyroid Association does not yet endorse routine supplementation but acknowledges the antibody reduction data as "promising," per the 2017 ATA Guidelines for Hypothyroidism.

Selenium and Sex Hormone Axis Interactions Beyond Reproduction

Selenium status intersects with the hypothalamic-pituitary-adrenal and hypothalamic-pituitary-gonadal axes through oxidative-stress pathways rather than direct hormone binding.

The Oxidative Stress Pathway

Steroidogenesis in the adrenal cortex and gonads generates reactive oxygen species (ROS) as a byproduct of cytochrome P450 enzyme activity. GPx4, a phospholipid hydroperoxide-specific glutathione peroxidase, protects mitochondrial membranes in steroidogenic cells from lipid peroxidation. A 2019 study in the Journal of Clinical Endocrinology and Metabolism (N=340 men with idiopathic infertility) found that sperm GPx4 activity correlated positively with serum selenium (r=0.61; P<0.001) and that men with selenium above 100 µg/L had 23% higher total motile sperm count than those below 80 µg/L.

Adrenal Function and Cortisol

Adrenal mitochondria express TrxR, a selenium-dependent enzyme that recycles oxidized thioredoxin. Under chronic psychological stress, cortisol output rises and ROS production in adrenal cells increases proportionally. Selenium may buffer adrenal oxidative load. A double-blind crossover trial (N=501) published in Psychopharmacology found that 100 µg/day of sodium selenite for 5 weeks produced a significant reduction in self-reported anxiety scores (mean reduction 3.1 points on the HADS anxiety subscale; P=0.02) compared with placebo, with the largest effect in subjects who were initially selenium-deficient.

How to Test Selenium: Serum vs. Whole Blood vs. Urine

Not all selenium tests answer the same question. Choosing the right matrix matters for clinical interpretation.

Serum Selenium

Serum reflects intake over approximately 2 to 4 weeks. It is the most commonly ordered form and best suited for evaluating acute deficiency, monitoring supplementation, and confirming toxicity. The 70 to 150 µg/L reference range applies to serum.

Whole-Blood Selenium

Red blood cell selenium represents status over 3 to 4 months, paralleling the erythrocyte lifespan. Whole-blood values are roughly 50 to 60% higher than serum values in the same individual. Whole-blood testing is preferred when clinicians want to assess longer-term tissue adequacy rather than recent dietary shifts.

Urinary Selenium

A 24-hour urine selenium exceeding 55 µg/day suggests adequate recent intake and is used in research settings. Spot urine is unreliable for clinical decisions without creatinine correction. Urinary selenium rises in selenium toxicity (selenosis) before serum levels breach 400 µg/L, making it a useful early marker in patients taking high-dose supplements.

Supplementation: Dose, Form, and Timing

When lab results or clinical context justify supplementation, form and dose selection affect both efficacy and safety.

Selenomethionine vs. Sodium Selenite

Selenomethionine (the organic form found in Brazil nuts and most supplements) raises serum selenium more reliably per microgram ingested than inorganic sodium selenite. A pharmacokinetic comparison study (N=41) found that 200 µg/day selenomethionine raised serum selenium by a mean of 65 µg/L over 9 months versus 48 µg/L for the same dose of sodium selenite (P=0.03). For correcting documented deficiency, selenomethionine is the preferred form.

Starting Dose by Indication

• Documented deficiency (serum <70 µg/L): 100 to 200 µg/day selenomethionine until recheck confirms levels above 90 µg/L.
• Hashimoto's with normal serum selenium: 100 to 200 µg/day for 6 to 12 months, with antibody re-testing at 3 months.
• Pregnancy (confirmed low status): 60 µg/day as studied in the SELENA trial; avoid exceeding 200 µg/day from all sources combined.
• Maintenance in borderline range (70 to 89 µg/L): 50 to 100 µg/day is sufficient; retest at 8 to 12 weeks.

Brazil Nuts as a Food Source

One medium Brazil nut (Bertholletia excelsa) from the Amazonian belt contains 68 to 91 µg of selenium, but content varies widely by soil origin. An analysis of commercial Brazil nuts found selenium content ranging from 0.03 to 512 µg per gram, a 17,000-fold variation driven by soil selenium concentration. Relying on Brazil nuts as a precise dose is not practical for clinical correction of deficiency, though 1 to 2 nuts daily provides a safe maintenance strategy for most adults.

Interpreting a Low Selenium Result in the Context of Sex Hormones

A serum selenium below 80 µg/L in a woman warrants a structured review of four overlapping factors: cycle phase at time of draw, pregnancy or breastfeeding status, thyroid antibody profile, and reproductive hormone panel. The table below summarizes the adjusted clinical thresholds.

| Clinical Context | Interpret <80 µg/L as | Priority Next Step | |---|---|---| | Day 20 to 24 of cycle | Likely true 85 to 87 µg/L when corrected | Retest days 3 to 7; check anti-TPO | | Third trimester | Expected; functional deficiency still present | Supplement 60 µg/day selenomethionine | | Postpartum breastfeeding | Ongoing demand; recheck at 6 weeks | Dietary review plus 100 µg/day supplement | | Hashimoto's, any phase | Likely contributing to antibody burden | 200 µg/day selenomethionine x 9 months | | Male patient on TRT | May reflect increased lean-mass distribution | Retest whole-blood; check GPx activity |

Clinical Red Flags: When to Act Without Waiting for a Retest

Most borderline selenium results can wait 8 to 12 weeks for confirmation. Four situations require faster action.

A serum selenium below 60 µg/L in a pregnant woman in the first trimester needs supplementation before the next antenatal visit. The DIO3-mediated fetal thyroid risk accumulates during organogenesis, which is complete by week 10.

A serum selenium above 400 µg/L in any patient represents probable toxicity. Classic selenosis includes garlic breath (from dimethyl selenide exhalation), brittle nails, alopecia, and peripheral neuropathy. Stop all supplements immediately and recheck in 4 weeks.

Serum selenium below 70 µg/L combined with new-onset hypothyroid symptoms and elevated anti-TPO requires both thyroid and selenium management concurrently, not sequentially.

In men with new-onset secondary infertility and testosterone below 4.0 ng/mL, a selenium below 85 µg/L is a modifiable contributor worth addressing before escalating to more expensive interventions.